Fundz

Wellumio closes an oversubscribed $9.75 million Pre-Series A round led by Nuance Connected Capital to accelerate its portable stroke imaging technology.

PRIVATEJul 24, 2026

Amount Raised

NZ$9.75 Million

Round Type

Pre-Series A

WellingtonBiotechnology

Investors

Flying KiwiCure Kids VenturesNz Growth Capital Partners (Nzgcp)’S Aspire Seed FundBoosterPacific ChannelIcehouse VenturesJumpspace VenturesBioshore VenturesEnterprise AngelsSnowball EffectNew Zealand Government’s Active Investor Plus (Aip) ProgrammeNuance Connected Capital

Description

Wellumio, a New Zealand medtech company, has raised $9.75 million in a Pre-Series A funding round. This round will help expand their team and advance clinical and product development for their Axana® brain imaging device. The investment was led by Nuance Connected Capital and included participation from various international investors. The funding aims to support clinical evaluation across additional sites and geographies.

Quick answer

Wellumio raised NZ$9.75 Million in a Pre-Series A round, dated July 24, 2026. Investors: Flying Kiwi, Cure Kids Ventures, Nz Growth Capital Partners (Nzgcp)’S Aspire Seed Fund, Booster, Pacific Channel, Icehouse Ventures, Jumpspace Ventures and Bioshore Ventures. Wellumio is based in Wellington, Wellington, New Zealand.

How much did Wellumio raise?
Wellumio raised NZ$9.75 Million in a Pre-Series A round on July 24, 2026.
Who invested in Wellumio?
Flying Kiwi, Cure Kids Ventures, Nz Growth Capital Partners (Nzgcp)’S Aspire Seed Fund, Booster, Pacific Channel, Icehouse Ventures, Jumpspace Ventures and Bioshore Ventures are named as investors in this round.
What does Wellumio do?
Wellumio is a New Zealand medtech company developing a portable stroke detection device called Axana.
Where is Wellumio based and how big is it?
Wellumio is based in Wellington, Wellington, New Zealand. Fundz records about 16 employees.
Who are the decision-makers at Wellumio?
Fundz holds 2 contacts at Wellumio, including the Chief Commercial Officer & Executive Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Wellumio that raised within 45 days of this round, from Fundz verified event records.

  • Seraxis raised $10M on September 7, 2026.
  • Simnova Biotech raised $60M (Series B) on September 6, 2026.
  • Hi Rasmus raised $50M on September 6, 2026.
  • Superluminal Medicines raised $60M (Series B) on September 6, 2026.
  • Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
  • Tensive S.r.l raised $23M (Debt Financing) on September 3, 2026.

Who to call at Wellumio, and when

A new round usually means Wellumio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Wellumio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Wellumio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Wellumio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Wellumio

Location

Wellington, Wellington, New Zealand

About

Wellumio is a New Zealand medtech company developing a portable stroke detection device called Axana. The technology is designed to rapidly detect acute strokes and unlock treatment in the crucial 'golden hour' where rapid intervention significantly improves outcomes. Wellumio's aim is to transform stroke care through innovative imaging solutions that allow for quicker diagnosis and treatment. The company has demonstrated strong progress and investor confidence in advancing its technology for global healthcare challenges.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Wellumio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsGyan, Chief Commercial Officer & Executive Di… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Wellumio's next move

See what Strategic adds

Wellumio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.